Katherine Kalin

Advances in molecular biology now make it possible to detect diseases sooner, allowing physicians to advise patients on optimal therapies. The Diagnostics and Personalized Medicine panel explores the changing world of diagnostics, bringing together executives, experienced venture capitalists, and a physician.